drugset / Trial / NCT04910802

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

NCT04910802

Phase 4 Recruiting 150000 enrolled Miriam Elfström Karolinska University Hospital · collab
NaSingle-groupOpen-labelPrevention

Summary

The study aims to evaluate whether organised, concomitant HPV vaccination and HPV screening offered to all resident women aged 22-27 will result in a more rapid elimination of HPV infection in Sweden. This objective will be examined at the population level.

Timeline

Start
2021-05-03
Primary completion
2025-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil 9 Vaccine